Biogen
Company Overview
Keywords
Description
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. Biogen applies deep understanding of human biology and leverages different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. The company's approach is to take bold risks, balanced with return on investment to deliver long-term growth. With approximately 7,000 employees worldwide, Biogen is a global organization headquartered in Cambridge, Massachusetts, with research operations in the same location. Its international headquarters are in Baar, Switzerland, and it operates world-class manufacturing facilities in North Carolina and Solothurn, Switzerland. Offering therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries, Biogen is committed to making a difference in healthcare. For more information, please visit www.biogen.com. Community Guidelines can be found at https://www.biogen.com/community-guidelines.html. Follow Biogen on social media platforms such as LinkedIn, Facebook, and YouTube for updates and insights.
Funding History
| Date | Round | Amount | Lead Investors |
|---|---|---|---|
| Sep 1, 2023 | Post-IPO Debt | $1,500,000,000 | JP Morgan |
Technology Stack
+620 more technologies
Key Employees
View AllFind Executive job changes at Biogen
Frequently Asked Questions
Employee Statistics
By Seniority
Key People
Christiano Silva
Vice President , General Manager Cluster Iberia Biogen
Madrid
LinkedInJulien Frescura
Associate Director , Customer Excellence and Operations Biosimilaire
Courbevoie
LinkedInPer Magnus Stare
Director , Information Technology Program Management
London, England
LinkedInShibeshih Mitiku Belachew
Vice President , Head of Science , Biogen Digital Health
Zürich
LinkedInSimilar Companies
Vertex Pharmaceuticals
Business Services
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and have made significant advancements in multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continue to progress clinical and research programs in these diseases. We also have a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where we have deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency. Our global HQ is in Boston, and we have research and development (R&D) sites and commercial offices worldwide. Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. We have also earned a spot on TIME Most Influential Companies, TIME Best Inventions, and Fast Company Most Innovative Companies lists. Our research and medicines have received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the Prix Galien, the Scrip Award and the Breakthrough Prize awards. Read our community guidelines: https://www.vrtx.com/vertexs-community-guidelines/
Waters Corporation
Business Services
Waters Corporation (NYSE: WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences for more than 60 years. With more than 7,800 employees worldwide, Waters operates directly in 35 countries, including 14 manufacturing facilities, and with products available in more than 100 countries. Learn more at www.waters.com.
Bruker
Business Services
Right from the beginning, more than sixty years ago, Bruker has been driven by a single idea: to provide the best technological solution for each analytical task. Today, worldwide, more than 9,700 employees in over 90 locations on all continents are focusing their efforts on this permanent challenge. Bruker systems cover a broad spectrum of applications in all fields of research and development and are used in all industrial production processes for the purpose of ensuring quality and process reliability. Bruker continues to build upon its extensive range of products and solutions, expand its broad base of installed systems, and maintain a strong reputation amongst its customers. As one of the world's leading analytical instrumentation companies, Bruker remains focused on developing state-of-the-art technologies and innovative solutions for today’s ever-complex analytical questions. Bruker - Innovation with Integrity. Privacy Policy: https://goto.bruker.com/LI-Bruker-PrivacyPolicy Imprint: Bruker Corporation 40 Manning Road Billerica, MA 01821, USA Contacts: - Phone: +1 978-663-3660 - Fax: +1 978-663-5585 - Email: pr@bruker.com